Inflammatory cytokines, including IL-32, TNF-α, IL-6, and IL-1β, have gene variants that enhance inflammation and the progression of MASLD to MASH and fibrosis [47]. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.